The evaluation incidence and risk factors of mortality among patients with end stage renal disease in Southeast Turkey

Basit Öğe Kaydı
dc.contributor.authorSit, Dede
dc.contributor.authorKadiroglu, Ali Kemal
dc.contributor.authorKayabasi, Hasan
dc.contributor.authorKara, Ismail Hamdi
dc.contributor.authorYilmaz, Zulfukar
dc.contributor.authorYilmaz, M. Emin
dc.date.accessioned2024-04-24T16:24:39Z
dc.date.available2024-04-24T16:24:39Z
dc.date.issued2008
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim. End stage renal disease (ESRD) presents with higher morbidity and mortality with respect to the general population. In recent study, the causes of mortality and associated risk factors in ESRD have been evaluated. Materials and Methods. In this study, 1538 patients diagnosed with ESRD in 10-year period were evaluated retrospectively. The patients were divided as dead (group 1) and alive (group 2). The patients' demographic features, causes of death, comorbidity at hospitalization, hematological and biochemical analyses, creatinine clearance at the beginning of hospitalization, daily urine volume, blood gas results, CRP value as inflammatory marker, ejection fraction, interventricular septum diameter, left ventricle posterior wall end-diastolic diameter, and left atrium diameter determined with echocardiography were recorded. Results. Mortality ratio of ESRD patients in a 10-year period was 14.1%. While the general mean age of all patients was 54.7 +/- 16.6 and male/female ratio was 781/757, these ratios were 66.3 +/- 21.8 and 114/103 in Group 1 and 52.8 +/- 21.7 and 667/654 in Group 2. One or more comorbid pathologies were present in 82.9% of Group 1. The most common cause of mortality was cardiovascular diseases (CVD), and the most common cause of comorbidity was infections. Older age, anemia, absence of residual renal function, hypoalbuminemia, inflammation, impaired Ca and P metabolism, and left ventricular hypertrophy were significantly higher in Group 1 than in Group 2. Conclusion. CVD are the most important preventable causes of morbidity and mortality in all stages of chronic kidney disease. Taking precaution against CVD and the associated complications will provide a positive contribution in reducing morbidity and mortality among ESRD patients.en_US
dc.identifier.doi10.1080/08860220701741965
dc.identifier.endpage44en_US
dc.identifier.issn0886-022X
dc.identifier.issn1525-6049
dc.identifier.issue1en_US
dc.identifier.pmid18197541
dc.identifier.scopus2-s2.0-38149101752
dc.identifier.scopusqualityQ2
dc.identifier.startpage37en_US
dc.identifier.urihttps://doi.org/10.1080/08860220701741965
dc.identifier.urihttps://hdl.handle.net/11468/16802
dc.identifier.volume30en_US
dc.identifier.wosWOS:000252405700006
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofRenal Failure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEnd-Stage Renal Diseaseen_US
dc.subjectAll-Causes Mortality And Morbidityen_US
dc.titleThe evaluation incidence and risk factors of mortality among patients with end stage renal disease in Southeast Turkeyen_US
dc.titleThe evaluation incidence and risk factors of mortality among patients with end stage renal disease in Southeast Turkey
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu